New migraine drug shows promise in trial

(Medical News Today) UPDATED 2008-10-25

A new drug called tonabersat has shown positive results for preventing migraine with aura in a new study, its maker has reported. Tonabersat was able to reduce the average number of migraine with aura attacks by 68 percent in the Phase II clinical trial, according to a news release from Minster Pharmaceuticals. Reseachers say the drug also reduced the number of migraine headache days suffered among the 31 study participants. Read full story >

See all Migraine News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyMigraineConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

MyMigraineConnection.com

New migraine drug shows promise in trial

People who read this also read...

What the community is saying...

Stackable Trigger Confusion

MigrainePuppet